YS Biopharma EGM Controversy: Shareholders in Revolt?
YS Biopharma raises concerns about the validity of an extraordinary general meeting called by shareholders. The company also faces financial ...
- Latest
- Trending
YS Biopharma raises concerns about the validity of an extraordinary general meeting called by shareholders. The company also faces financial ...
FDA approves Takeda's EOHILIA as first-line treatment for Eosinophilic Esophagitis. Groundbreaking oral therapy offers hope for improved quality of life.
Akoustis Technologies secures major order for Wi-Fi 7 filters from a top-tier US-based carrier, supporting planned production increase in September ...
ContextLogic, the company behind Wish, will sell most of its assets to Qoo10 for $173M in cash. This move aims ...
Employers can now match a percentage of an employee's student loan payment and direct it into a retirement plan under ...
Explore the number of Dogecoins in circulation and the impact of its uncapped supply on the crypto market. Uncertainty about ...
Oppenheimer lowers price target on Gilead Sciences after Q4 earnings report and challenges in drug pipeline. Optimistic about prospects for ...
As global shocks and technological advancements reshape the financial landscape, financial firms must embrace advanced technology for compliance or face ...
GCEX partners with Crossover Markets Group for spot cryptocurrency transactions. The collaboration aims to cater to the growing demand for ...
Global gaming technology provider, Intralot, is investing in cutting-edge technologies and promoting Greece as a technological hub. With a strong ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.